Published in Diabetes Care on May 07, 2012
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol (2015) 1.06
Modelling self-management pathways for people with diabetes in primary care. BMC Fam Pract (2015) 0.80
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010. Acta Ophthalmol (2013) 0.76
Assessment of macular function using the SKILL Card in adults with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci (2014) 0.76
Screening Intervals for Diabetic Retinopathy and Implications for Care. Curr Diab Rep (2017) 0.75
Update on Diagnosis and Treatment of Diabetic Retinopathy: A Consensus Guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society). J Ophthalmol (2017) 0.75
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine. Diabetologia (2017) 0.75
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet (2003) 4.93
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Retinopathy in diabetes. Diabetes Care (2004) 4.25
The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care (2001) 2.95
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci (1998) 2.65
Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health (2009) 2.44
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31
Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med (2010) 1.78
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care (2009) 1.55
Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia (2011) 1.44
Effective diabetes care: a need for realistic targets. BMJ (2002) 1.43
Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med (2003) 1.40
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol (2007) 1.34
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care (2005) 1.34
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology (2003) 1.30
Diabetic retinopathyA clinical update. Diabetologia (2002) 1.26
The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med (2002) 1.22
Prediction of adherence and control in diabetes. J Behav Med (1993) 1.14
Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol (2003) 1.12
Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands. Diabetes Care (2011) 1.07
Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med (2007) 0.93
Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care (2011) 0.84
Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med (2010) 3.24
A multidimensional conceptual framework for analysing public involvement in health services research. Health Expect (2008) 2.93
Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab (2009) 2.31
Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2004) 1.58
Hyperacute stroke care and NHS England's business plan. BMJ (2014) 1.57
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU Int (2011) 1.51
Phaeochromocytoma. BMJ (2012) 1.48
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value Health (2011) 1.48
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant (2007) 1.47
Public health implications of establishing a national programme to screen young athletes in the UK. Br J Sports Med (2009) 1.38
The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs (2008) 1.21
A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab (2008) 1.15
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2013) 1.15
A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet (2013) 1.12
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2008) 1.11
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness. Am J Rhinol (2006) 1.11
Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies. Implement Sci (2012) 1.06
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract (2006) 1.05
Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function. J Clin Endocrinol Metab (2008) 1.02
Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev (2011) 1.02
Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther (2011) 1.02
Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke (2012) 1.01
Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab (2011) 1.00
Addison disease in adults: diagnosis and management. Am J Med (2010) 0.99
Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab (2009) 0.95
Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health (2009) 0.92
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review. BMC Health Serv Res (2013) 0.92
Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) (2007) 0.92
Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction. BMC Health Serv Res (2013) 0.92
Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr (2012) 0.92
The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol (2009) 0.92
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics (2008) 0.90
The clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review. PLoS One (2013) 0.90
Effectiveness of mealtime interventions on nutritional outcomes for the elderly living in residential care: a systematic review and meta-analysis. Ageing Res Rev (2013) 0.89
Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis? Stroke (2012) 0.89
A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur J Endocrinol (2011) 0.89
Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. Pharmacoeconomics (2005) 0.89
The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis. Clin Endocrinol (Oxf) (2007) 0.88
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics (2013) 0.88
Chemotherapeutic wafers for High Grade Glioma. Cochrane Database Syst Rev (2008) 0.88
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis. BMC Geriatr (2014) 0.87
Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) (2008) 0.87
A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG (2004) 0.87
Implementing the evidence for preventing falls among community-dwelling older people: a systematic review. J Safety Res (2011) 0.87
Management of hyperthyroidism during pregnancy in Asia. Endocr J (2014) 0.86
Establishing local priorities for a health research agenda. Health Expect (2012) 0.85
A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT). BMJ Open (2013) 0.85
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health (2009) 0.84
Severe hypothyroidism after thalidomide treatment. J R Soc Med (2004) 0.84
Interventions to reduce acute paediatric hospital admissions: a systematic review. Arch Dis Child (2012) 0.84
Five-year follow-up for women with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab (2013) 0.83
Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract (2006) 0.83
Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction? Int J Cardiol (2008) 0.83
Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol (2011) 0.83
Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy. J Thyroid Res (2011) 0.82
Pituitary apoplexy within a macroprolactinoma. Nat Clin Pract Endocrinol Metab (2008) 0.81
Phenotypic multiple endocrine neoplasia type 2B, without endocrinopathy or RET gene mutation: implications for management. Thyroid (2006) 0.81
TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab (2014) 0.80
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. J Clin Endocrinol Metab (2014) 0.79
Screening and management of hypothyroidism in pregnancy: results of an Asian survey. Endocr J (2014) 0.79
Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care (2012) 0.79
Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial. Clin Rehabil (2010) 0.78
Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na+-K+ leak in a xerocytic form. Br J Haematol (2004) 0.77
Involving patients in drug licensing decisions. BMJ (2013) 0.77
What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease. Eur J Endocrinol (2006) 0.77
Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease. J Clin Endocrinol Metab (2012) 0.76
Thyroid function: New guidelines for the management of hypothyroidism. Nat Rev Endocrinol (2012) 0.75
Correction: Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus. PLoS One (2015) 0.75
Carpopedal spasm in an elderly man: an unusual presentation of coeliac disease. J R Soc Med (2007) 0.75
CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy. Clin Rheumatol (2004) 0.75
A modelling tool for capacity planning in acute and community stroke services. BMC Health Serv Res (2016) 0.75
Predictive value of asthma medication to identify asthma sufferers. Br J Gen Pract (2002) 0.75
Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis. Pharmacoeconomics (2015) 0.75
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis. Pharmacoeconomics (2012) 0.75
Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review. BJOG (2005) 0.75
A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula. J Public Health (Oxf) (2007) 0.75
The 7th IMA international conference on quantitative modelling in the management of health and social care: IMA health 2013 special issue. Health Care Manag Sci (2014) 0.75
A woman with episodic headaches, sweating, and palpitations. BMJ (2011) 0.75
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists. J Clin Endocrinol Metab (2014) 0.75
An elderly woman with recurrent episodes of confusion. BMJ (2010) 0.75
Amiodarone-induced thyrotoxicosis, an overview of UK management. Clin Endocrinol (Oxf) (2012) 0.75
NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Lancet Oncol (2011) 0.75
Mind sharpeners for scientists: the EQUATOR Network. Int J Technol Assess Health Care (2011) 0.75
Investigating hypokalaemia. BMJ (2013) 0.75
Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care (2009) 0.75
Adult attention deficit hyperactivity disorder (ADHD): public health implications. Perspect Public Health (2012) 0.75